Phytotherapeutic Approaches and Ethnopharmacological Responses Against COVID-19 doi.org/10.26538/tjnpr/v5i7.7
Main Article Content
Abstract
The coronavirus disease 2019 (COVID-19) pandemic, the most important public health problem in 2020, poses severe health and socioeconomic impact. Many people turn to herbal therapy to prevent infection with the virus or alleviate the symptoms caused by it. This study evaluates the patterns of phytotherapy-based product utilization in the prevention against SARS-COV-2 and their reported effectiveness. This cross-sectional survey used a convenience sample of 287 adults who had used any form of hytotherapeutics to help fight and/or treat COVID-19 infection. The majority (n = 194, 67.6%) of participants had used plants from the Rutaceae family (like lemon and oranges), followed by those of Amaryllidaceous (namely, Garlic and Onion). Participants said that physicians and pharmacists were the primary sources of information about phytotherapy (n=107, 37.3%), and their decision was driven by their positive attitude towards herbal medicine or plant-based products (n=133, 46.3%). Many participants did not notice any side effects of these remedies (n=270, 94%) and believed they were effective (n = 184, 64%). This study provides an overview of the many phytotherapeutic remedies used in the era of COVID-19 by Jordanian society, which could prompt the conduction of interventional trials to assess the effectiveness and safety of this modality of therapy, either as a stand-alone or adjuvant treatment.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Tayseer I, Aburjai T, Abu-Qatouseh L, AL-Karabieh N, Ahmed W, Al-Samydai A. In vitro Anti-Helicobacter Pylori Activity of Capsaicin. J Pure Appl Microbiol. 2020; 14(1):279-286.
Al-Samydai A, Al-Mamoori F, Abdelnabi H, Aburjai T. An updated review on anticancer activity of capsaicin. Int J Sci Technol Res. 2019; 8:2625-2631.
Kamal SM, Al-Samydai A, Yousif RO, Aburjai T. The Impact of SARS-COV-2 Quarantine on Children‗s Behaviors and Language. Int J Res Pharm Sci. 2020; 11:796-806.
Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in microbiology. 2016; 24(6):490-502.
Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020; 10(2):102-108.
Pearce L, Davidson SM, Yellon DM. The cytokine storm of COVID-19: a spotlight on prevention and protection. Expert Opin Ther Targets. 2020; 24(8):723-730.
Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M, Lofgren SM, Williams DA, Okafor EC, Pullen MF, Nicol MR, Nascene AA. Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial. Ann Intern Med. 2020; 173(8):623-631.
Mehra MR, Ruschitzka F, Patel AN. RetractionHydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. 2020; 395(10240):1820.
Gautret P, Lagier JC, Parola P, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honoré S. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020; 56(1):105949.
Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, Wang D, Liu C, Meng Y, Cui L, Yu J. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19). J Int Med. 2020; 288(1):128-138.
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 2020; 395(10236):1569-1578.
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020; 382(19):1787-1799.
Bozin B, Mimica-Dukic N, Samojlik I, Jovin E. Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils. J Agric Food Chem. 2007; 55(19):7879-7885.
Dragos D, Gilca M, Gaman L, Vlad A, Iosif L, Stoian I, Lupescu O. Phytomedicine in joint disorders. Nutrients. 2017; 9(1):70-88.
Vinson JA, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomed. 2005; 12(10):760-765.
Lelli D, Sahebkar A, Johnston TP, Pedone C. Curcumin use in pulmonary diseases: State of the art and future perspectives. Pharmacol Res. 2017; 115:133-48.
Nugraha RV, Ridwansyah H, Ghozali M, Khairani AF, Atik N. Traditional herbal medicine candidates as complementary treatments for COVID-19: A Review of Their Mechanisms, Pros and Cons. Evid-Based Compl Altern Med. 2020; 10:1-12.
Iannarelli R, Marinelli O, Morelli MB, Santoni G, Amantini C, Nabissi M, Maggi F. Aniseed (Pimpinella anisum L.) essential oil reduces pro-inflammatory cytokines and stimulates mucus secretion in primary airway bronchial and tracheal epithelial cell lines. Indust Crops Prod. 2018; 114:81-86.
Mencherini T, Cau A, Bianco G, Loggia RD, Aquino RP, Autore G. An extract of Apium graveolens var. dulce leaves: Structure of the major constituent, apiin, and its anti‐inflammatory properties. J Pharm Pharmacol. 2007; 59(6):891-897.
Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R. COVID-19 and therapy with essential oils having antiviral, antiinflammatory, and immunomodulatory properties. Inflammopharmacol. 2020; 14:1-9.
Sharifi-Rad J, Mnayer D, Tabanelli G, Stojanović-Radić ZZ, Sharifi-Rad M, Yousaf Z, Vallone L, Setzer WN, Iriti M. Plants of the genus Allium as antibacterial agents: From tradition to pharmacy. Cell Mol Biol. 2016; 62(9):57-68.
Khubber S, Hashemifesharaki R, Mohammadi M, Gharibzahedi SM. Garlic (Allium sativum L.): a potential unique therapeutic food rich in organosulfur and flavonoid compounds to fight with COVID-19. Nutr J. 2020; 19(1):1-3.
Pandey P, Khan F, Kumar A, Srivastava A, Jha NK. Screening of Potent Inhibitors Against 2019 Novel Coronavirus (Covid-19) from Alliumsativum and Allium cepa: An In Silico Approach. Biointerface Res Appl Chem. 2021; 11(1):7981-7993.
Fuchs S, Hsieh LT, Saarberg W, Erdelmeier CA, Wichelhaus TA, Schaefer L, Koch E, Fürst R. Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti‐inflammatory activities in vitro and in vivo. J Cell Mol Med. 2015; 19(5):1021-1032.
Heinrich M, Williamson EM, Gibbons S, Barnes J, PrietoGarcia J. Fundamentals of Pharmacognosy and Phytotherapy EBook. Elsevier Health Sciences; 2017; 24p.
Capelari-Oliveira P, Paula CA, Rezende SA, Campos FT, Grabe-Guimarães A, Lombardi JA, Saúde-Guimarães DA. Antiinflammatory activity of Lychnophora passerina, Asteraceae (Brazilian ―arnica‖). J Ethnopharmacol. 2011; 135(2):393-398.
Chicaro P, Pinto E, Colepicolo P, Lopes JL, Lopes NP. Flavonoids from Lychnophora passerina (Asteraceae): potential antioxidants and UV-protectants. Biochem Sys Ecol. 2004; 32(3):239-243.
García-Mediavilla V, Crespo I, Collado PS, Esteller A, Sánchez-Campos S, Tuñón MJ, González-Gallego J. The antiinflammatory lavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol. 2007; 557(2-3):221-9.
Siracusa L, Saija A, Cristani M, Cimino F, D'Arrigo M, Trombetta D, Rao F, Ruberto G. Phytocomplexes from liquorice (Glycyrrhiza glabra L.) leaves—Chemical characterization and evaluation of their antioxidant, anti-genotoxic and antiinflammatory activity. Fitoter. 2011; 82(4):546-556.
Bottamedi M, dos Santos Nascimento MV, Fratoni E, Moon YJ, Faqueti L, Tizziani T, Sandjo LP, Siminski A, Dalmarco EM, Mendes BG. Antioxidant anti-inflammatory action (in vivo and in vitro) from the trunk barks of Cabreúva (Myrocarpus frondosus Allemao, Fabaceae). J Ethnopharmacol. 2021; 267:113545.
Hajhashemi V, Ghannadi A, Sedighifar S. Analgesic and antiinflammatory properties of the hydroalcoholic, polyphenolic and boiled extracts of Stachys lavandulifolia. Res Pharm Sci. 2007; 1(2):92-98.
Singh RS, Singh AK, Shukla KK, Tripathi AK. COVID-19 Pandemic: Evidences from Clinical Studies. J Commun Pub Health Nurs. 2020; 6 (4):1-21.
Yan L, Song F, Li H, Li Y, Li J, He QY, Zhang D, Wang F, Zhang M, Zhao H, Feng T. Submicron emulsion of cinnamaldehyde ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibition of inflammation, oxidative stress and epithelial-mesenchymal transition. Biomed Pharmacother. 2018; 102:765-771.
Kulkarni SA, Nagarajan SK, Ramesh V, Palaniyandi V, Selvam SP, Madhavan T. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. J Mol Strut. 2020; 1221:128823.
Riaz G and Chopra R. A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L. Biomed Pharmacother. 2018; 102:575-586.
Lee YM, Yoon Y, Yoon H, Park HM, Song S, Yeum KJ. Dietary anthocyanins against obesity and inflammation. Nutr. 2017; 9(10):1089.
Khalifa I, Nawaz A, Sobhy R, Althwab SA, Barakat H. Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CLpro of 2019-nCoV than monomeric anthocyanins: A structural-relationship activity study with 10 anthocyanins using in-silico approaches. J Mol Graph Model. 2020; 1(100):107690.
Dhanasekaran S. Scope of phytotherapeutics in targeting ACE2 mediated Host-Viral Interface of SARS‐CoV2 that causes COVID-19. ChemRxiv. 2020; 1(1):1-15.
Goldoni FC, Barretta C, Nunes R, Broering MF, De Faveri R, Molleri HT, Corrêa TP, Farias IV, Amorin CK, Pastor MV, Meyre-Silva C. Effects of Eugenia umbelliflora O. Berg (Myrtaceae)-leaf extract on inflammation and hypersensitivity. J Ethnopharmacol. 2019; 244:112133.
Lazarini JG, Sardi JD, Franchin M, Nani BD, Freires IA, Infante J, Paschoal JA, de Alencar SM, Rosalen PL. Bioprospection of Eugenia brasiliensis, a Brazilian native fruit, as a source of antiinflammatory and antibiofilm compounds. Biomed Pharmacother. 2018; 102:132-139.
Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, Marron TU. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020; 26(10):1636-1643.
Hollebeeck S, Winand J, Hérent MF, During A, Leclercq J, Larondelle Y, Schneider YJ. Anti-inflammatory effects ofpomegranate (Punica granatum L.) husk ellagitannins in Caco-2 cells, an in vitro model of human intestine. Food Func. 2012; 3(8):875-885.
Pinheiro AJ, Gonçalves JS, Dourado ÁW, de Sousa EM, Brito NM, Silva LK, Batista MC, de Sá JC, Monteiro CR, Fernandes ES, Monteiro-Neto V. Punica granatum L. leaf extract attenuates lung inflammation in mice with acute lung injury. J Immunol Res. 2018; 2018(1):1-11.
Carbonell-Caballero J, Alonso R, Ibañez V, Terol J, Talon M, Dopazo J. A phylogenetic analysis of 34 chloroplast genomes elucidates the relationships between wild and domestic species within the genus Citrus. Mol Biol Evol. 2015; 32(8):2015-2035.
Ghorbanpour M, Hadian J, Nikabadi S, Varma A. (2017) Importance of Medicinal and Aromatic Plants in Human Life. In: Ghorbanpour M, Varma A. (eds) Medicinal Plants and Environmental Challenges. Springer, Cham. 2017; 1-23p.
Brouqui P, Giraud-Gatineau A, Raoult D. Critical reappraisal of remdesivir investigational trials in COVID-19. New Microb New Infect. 2020; 38:100745.
Chen H and Du Q. Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Med Pharmacol. 2020; Preprints. 1-17.
Scoparo CT, de Souza LM, Rattmann YD, Kiatkoski EC, Dartora N, Iacomini M. The protective effect of green and black teas (Camellia sinensis) and their identified compounds against murine sepsis. Food Res Int. 2016; 83:102-111.
Gopalsamy B, Farouk AA, Mohamad TA, Sulaiman MR, Perimal EK. Antiallodynic and antihyperalgesic activities of zerumbone via the suppression of IL-1β, IL-6, and TNF-α in a mouse model of neuropathic pain. J Pain Res. 2017; 10:2605.
Soni VK, Mehta A, Ratre YK, Tiwari AK, Amit A, Singh RP, Sonkar SC, Chaturvedi N, Shukla D, Vishvakarma NK. Curcumin, a traditional spice component, can hold the promise against COVID-19?. Eur J Pharmacol. 2020; 12:173551.